Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...

Latest figures show that around 3.8m people in the UK, approximately one in 17, has Covid. Data from the Office for National Statistics (ONS) released earlier this week found that this was a 7 per ...

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a new trial out today. Published in Cell Reports Medicine, a team of researchers from the ...

Lateral flow tests (LFTs) are widely used across healthcare, food safety and environmental monitoring, providing rapid, on-site results. But challenges with sensitivity, flexibility and usability ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

We preselected all newsletters you had before unsubscribing.

Biotech company Senzo just raised a $2 million round at a $20 million pre-money valuation to further extend options for lateral flow diagnostics. “Lateral flow,” in this case, is the same type of ...